Data is not available at this time.
Ihara Science Corporation operates in the industrial manufacturing sector, specializing in high-pressure fittings, valves, hoses, and precision piping systems. The company serves diverse markets, including Japan, North America, Europe, and Asia-Pacific, catering to industries requiring robust fluid control solutions. Its product portfolio includes double ferrule fittings, metal gasket seal valves, and stainless steel tubes, positioning it as a critical supplier for sectors like petrochemicals, energy, and industrial automation. With a legacy dating back to 1941, Ihara Science has built a reputation for reliability and technical expertise in metal fabrication. The company’s revenue model hinges on both direct sales and long-term industrial partnerships, leveraging its engineering capabilities to maintain a competitive edge in precision fluid handling components. While facing competition from global industrial suppliers, its niche focus on high-pressure applications and regional distribution network strengthens its market positioning.
In FY 2022, Ihara Science reported revenue of JPY 20.6 billion, with net income of JPY 3.3 billion, reflecting a healthy net margin of approximately 16%. Operating cash flow stood at JPY 973 million, though capital expenditures of JPY 441 million indicate moderate reinvestment. The company’s profitability metrics suggest efficient cost management, supported by its focus on high-margin precision components.
The company’s diluted EPS of JPY 307.27 underscores its earnings power, driven by stable demand for industrial fittings and valves. With a conservative debt profile (JPY 540 million total debt) and JPY 6.8 billion in cash, Ihara Science maintains strong capital efficiency, allowing flexibility for strategic investments or shareholder returns.
Ihara Science’s balance sheet is robust, with cash and equivalents covering its total debt by over 12x. The low debt-to-equity ratio and ample liquidity position the company favorably for cyclical downturns or expansion opportunities, reflecting prudent financial management.
While specific growth rates are undisclosed, the company’s global footprint and product diversification suggest resilience. A dividend of JPY 65 per share indicates a commitment to shareholder returns, though payout ratios remain sustainable given its earnings and cash reserves.
With a market cap of JPY 32.1 billion and a beta of 0.54, Ihara Science is perceived as a lower-volatility industrial play. Its valuation likely reflects steady demand for industrial components, though investor expectations may hinge on regional economic conditions and sectoral capex trends.
Ihara Science’s technical expertise and long-standing client relationships provide a defensive moat. The outlook remains stable, supported by industrial demand, though global supply chain dynamics and competition warrant monitoring.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |